JNJ-42160443

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JNJ-42160443, covering 2016-01-22 to 2016-06-06. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain [Phase 2]

See pricing